A study by All India Institute of Medical Sciences (AIIMS) has revealed that chronic pulmonary aspergillosis (CPA), a common fungal infection, can be fatal for nearly one-third of lung disease patients. CPA, caused by Aspergillus mold spores, leads to gradual lung scarring, breathlessness, weight loss, and coughing up blood.
Published in Lancet Infectious Diseases, the study highlighted that 32% of lung disease patients diagnosed with CPA could die within five years, while 15% could succumb within the first year. Patients with prior tuberculosis (TB) had a lower five-year mortality rate of 25%. However, CPA is often misdiagnosed as TB, resulting in inadequate treatment. Antifungal drugs or surgery are critical for improving symptoms and reducing death risk.
The study also identified that older adults and those with interstitial lung disease, cancer, or smoking-related conditions face higher mortality risks.
Disclaimer: The information provided in this article is for general informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Also Read: Progress Against Tuberculosis: India’s Remarkable Achievements Highlighted in WHO’s 2024 Report
Follow US